Sector Gamma As as of Sept. 30, 2018
Portfolio Holdings for Sector Gamma As
Sector Gamma As holds 31 positions in its portfolio as reported in the September 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Abbott Laboratories (ABT) | 11.3 | $72M | 982k | 73.36 | |
| Baxter International (BAX) | 8.5 | $54M | 706k | 77.09 | |
| Boston Scientific Corporation (BSX) | 8.3 | $53M | 1.4M | 38.50 | |
| Merck & Co (MRK) | 8.1 | $52M | 731k | 70.94 | |
| Bristol Myers Squibb (BMY) | 7.0 | $45M | 721k | 62.08 | |
| Shire | 5.8 | $37M | 205k | 181.27 | |
| PerkinElmer (RVTY) | 5.6 | $36M | 369k | 97.27 | |
| Bio-Rad Laboratories (BIO) | 4.8 | $30M | 97k | 312.99 | |
| NuVasive | 4.4 | $28M | 395k | 70.98 | |
| Gilead Sciences (GILD) | 3.9 | $25M | 323k | 77.21 | |
| Anthem (ELV) | 3.6 | $23M | 84k | 274.05 | |
| Integra LifeSciences Holdings (IART) | 3.5 | $22M | 339k | 65.87 | |
| Perrigo Company (PRGO) | 3.5 | $22M | 313k | 70.80 | |
| Agilent Technologies Inc C ommon (A) | 2.4 | $15M | 213k | 70.54 | |
| Incyte Corporation (INCY) | 2.3 | $15M | 214k | 69.08 | |
| Universal Health Services (UHS) | 2.1 | $13M | 105k | 127.84 | |
| Biogen Idec (BIIB) | 2.0 | $13M | 36k | 353.31 | |
| Patterson Companies (PDCO) | 1.8 | $12M | 478k | 24.45 | |
| Ionis Pharmaceuticals (IONS) | 1.6 | $10M | 202k | 51.58 | |
| Lexicon Pharmaceuticals (LXRX) | 1.4 | $9.2M | 863k | 10.67 | |
| Cardinal Health (CAH) | 1.1 | $7.4M | 136k | 54.00 | |
| AstraZeneca (AZN) | 1.1 | $7.2M | 183k | 39.57 | |
| Portola Pharmaceuticals | 1.1 | $7.2M | 270k | 26.63 | |
| Dr. Reddy's Laboratories (RDY) | 0.9 | $5.9M | 171k | 34.60 | |
| Clovis Oncology | 0.8 | $5.5M | 186k | 29.37 | |
| Array BioPharma | 0.8 | $5.1M | 334k | 15.20 | |
| Alnylam Pharmaceuticals (ALNY) | 0.6 | $4.0M | 45k | 87.53 | |
| Sangamo Biosciences (SGMO) | 0.4 | $2.6M | 155k | 16.95 | |
| Ultragenyx Pharmaceutical (RARE) | 0.3 | $2.2M | 29k | 76.34 | |
| Spark Therapeutics | 0.3 | $1.8M | 34k | 54.56 | |
| Eli Lilly & Co. (LLY) | 0.2 | $1.5M | 14k | 107.33 |
